Milla Pharmaceuticals, an A.forall company

Milla Pharmaceuticals, an A.forall company, specializes in the development, licensing/acquisition, and commercialization of generic prescription drugs, with a strong focus on niche injectable and solution products for hospitals and clinics in the U.S. market. As part of the A.forall group, which is headquartered in Anderlecht, Belgium, and has offices in Ireland and the United States, Milla Pharmaceuticals benefits from the group's extensive distribution network and global presence. The company, founded in 2016, is committed to serving the Health Care, Manufacturing, and Pharmaceutical industries. With 144 employees, Milla Pharmaceuticals is positioned to leverage A.forall's successful track record in generics, boasting around 30 molecules on the European and US markets in addition to a strong pipeline of niche, complex, and value-added products. As of now, there is no available information on the last investment and the involved investors. Milla Pharmaceuticals presents a promising opportunity in the pharmaceutical sector, backed by the strength and resources of the A.forall group.